Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT02338232 · TERMINATED
Trial details
- NCT number
- NCT02338232
- Sponsor
- Hackensack Meridian Health
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-07
- Primary completion
- 2023-01-05
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.